Patent · US Active

Antibodies for determining the prothrombin fragment F2/F1+2 in a homogeneous immunoassay

US9096674B2 · kind B2 · utility

0Cited by

11References

18Claims

0Family size

Assignee

Siemens Healthcare Diagnostics Products GmbH · DE

Inventors

Matthias Ehm · Lippstadt, DE
Bodo Fischer · Marburg, DE
Harald Althaus · Wetter, DE
Roland Barten · Marburg, DE
Stefan Teigelkamp · Niederwalgern, DE

Key dates

Filing date	Sep 24, 2009
Grant date	Aug 4, 2015
Priority date	—
Expiry date	Jan 17, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/96463
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention is in the area of coagulation analysis and relates to antibodies which bind specifically to an immune complex of prothrombin fragment F2/F1+2 and an F2/F1+2 neoepitope-specific antibody fragment, and to the preparation and the use thereof in methods for determining F2/F1+2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.